Market open

Reviva Pharmaceuticals/RVPH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Ticker

RVPH
Trading on

Industry

Pharmaceuticals

Employees

15

RVPH Metrics

BasicAdvanced
$41M
Market cap
-
P/E ratio
-$1.29
EPS
-0.10
Beta
-
Dividend rate
$41M
-0.1
$6.80
$0.60
323K
0.519
0.443
-3.435
-233.95%
1,628.60%
-6.07
-6.07
-0.971
-19.09%
24.98%

What the Analysts think about RVPH

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Reviva Pharmaceuticals stock.

RVPH Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

RVPH Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy RVPH

$

Sign up or log in to buy
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Reviva Pharmaceuticals stock?

Reviva Pharmaceuticals (RVPH) has a market cap of $41M as of October 15, 2024.

What is the P/E ratio for Reviva Pharmaceuticals stock?

The price to earnings (P/E) ratio for Reviva Pharmaceuticals (RVPH) stock is 0 as of October 15, 2024.

Does Reviva Pharmaceuticals stock pay dividends?

No, Reviva Pharmaceuticals (RVPH) stock does not pay dividends to its shareholders as of October 15, 2024.

When is the next Reviva Pharmaceuticals dividend payment date?

Reviva Pharmaceuticals (RVPH) stock does not pay dividends to its shareholders.

What is the beta indicator for Reviva Pharmaceuticals?

Reviva Pharmaceuticals (RVPH) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.